158 related articles for article (PubMed ID: 32043469)
1. Cardioembolic acute cerebral micro-infarcts in the context of atrial fibrillation after low-dose intravenous infusion of lacosamide.
Corbellini ÁB; Torre PP; Hristova VN; Sanz BZ; García ACC; Jorge FR; García JLC; Díaz PP; Catevilla FJB
Epileptic Disord; 2020 Feb; 22(1):83-89. PubMed ID: 32043469
[TBL] [Abstract][Full Text] [Related]
2. Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures.
Degiorgio CM
Epilepsy Behav; 2010 Jul; 18(3):322-4. PubMed ID: 20570216
[TBL] [Abstract][Full Text] [Related]
3. Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review.
Kaufman KR; Velez AE; Wong S; Mani R
Epilepsy Behav Case Rep; 2013; 1():22-5. PubMed ID: 25688049
[TBL] [Abstract][Full Text] [Related]
4. Cardiac effects of rapid intravenous loading of lacosamide in patients with epilepsy.
Kim HK; Lee H; Bae EK; Kim DW
Epilepsy Res; 2021 Oct; 176():106710. PubMed ID: 34265537
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of intravenous lacosamide in status epilepticus.
Santamarina E; Toledo M; Sueiras M; Raspall M; Ailouti N; Lainez E; Porta I; De Gracia R; Quintana M; Alvarez-Sabín J; Xavier Salas Puig XS
J Neurol; 2013 Dec; 260(12):3122-8. PubMed ID: 24122063
[TBL] [Abstract][Full Text] [Related]
6. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy.
Santamarina E; González-Cuevas M; Toledo M; Jiménez M; Becerra JL; Quílez A; Suller A; Mauri JA; Fernández Á; Marinas A; Quintana M; Puig XS
Epilepsy Behav; 2018 Jul; 84():93-98. PubMed ID: 29758445
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
[TBL] [Abstract][Full Text] [Related]
8. Intravenous lacosamide in clinical practice-Results from an independent registry.
Lang N; Lange M; Schmitt FC; Bös M; Weber Y; Evers S; Burghaus L; Kellinghaus C; Schubert-Bast S; Bösel J; Lammers T; Sabolek M; van Baalen A; Dziewas R; Kraft A; Ruf S; Stephani U
Seizure; 2016 Jul; 39():5-9. PubMed ID: 27161669
[TBL] [Abstract][Full Text] [Related]
9. Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population.
d'Orsi G; Pascarella MG; Martino T; Carapelle E; Pacillo F; Di Claudio MT; Mancini D; Trivisano M; Avolio C; Specchio LM
Seizure; 2016 Nov; 42():20-28. PubMed ID: 27693808
[TBL] [Abstract][Full Text] [Related]
10. Intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly: a proof-of-concept, observational study.
Belcastro V; Vidale S; Pierguidi L; Sironi L; Tancredi L; Striano P; Taborelli A; Arnaboldi M
Seizure; 2013 Dec; 22(10):905-7. PubMed ID: 23953988
[TBL] [Abstract][Full Text] [Related]
11. Comparison of lacosamide versus sodium valproate in status epilepticus: A pilot study.
Misra UK; Dubey D; Kalita J
Epilepsy Behav; 2017 Nov; 76():110-113. PubMed ID: 28919386
[TBL] [Abstract][Full Text] [Related]
12. The Safety and Effectiveness of Intravenous Lacosamide for Refractory Status Epilepticus in the Critically Ill.
Newey CR; Le NM; Ahrens C; Sahota P; Hantus S
Neurocrit Care; 2017 Apr; 26(2):273-279. PubMed ID: 27844464
[TBL] [Abstract][Full Text] [Related]
13. Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400 mg loading doses.
Legros B; Depondt C; Levy-Nogueira M; Ligot N; Mavroudakis N; Naeije G; Gaspard N
Neurocrit Care; 2014 Jun; 20(3):484-8. PubMed ID: 23896816
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficiency of Intravenous Push Lacosamide Administration.
Davidson KE; Newell J; Alsherbini K; Krushinski J; Jones GM
Neurocrit Care; 2018 Dec; 29(3):491-495. PubMed ID: 29949010
[TBL] [Abstract][Full Text] [Related]
15. Intravenous lacosamide in status epilepticus: Correlation between loading dose, serum levels, and clinical response.
Perrenoud M; André P; Alvarez V; Stähli C; Decosterd LA; Rossetti AO; Novy J
Epilepsy Res; 2017 Sep; 135():38-42. PubMed ID: 28622537
[TBL] [Abstract][Full Text] [Related]
16. Intravenous lacosamide in status epilepticus and seizure clusters.
Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
Epilepsia; 2011 Oct; 52(10):e148-52. PubMed ID: 21801171
[TBL] [Abstract][Full Text] [Related]
17. Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
Shibata M; Hoshino R; Shimizu C; Sato M; Furuta N; Ikeda Y
BMC Neurol; 2021 Jun; 21(1):217. PubMed ID: 34102997
[TBL] [Abstract][Full Text] [Related]
18. Lacosamide as a new treatment option in status epilepticus.
Höfler J; Trinka E
Epilepsia; 2013 Mar; 54(3):393-404. PubMed ID: 23293881
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide in status epilepticus: Systematic review of current evidence.
Strzelczyk A; Zöllner JP; Willems LM; Jost J; Paule E; Schubert-Bast S; Rosenow F; Bauer S
Epilepsia; 2017 Jun; 58(6):933-950. PubMed ID: 28295226
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Chronic Treatment with Lacosamide and Topiramate on Cognitive Functions and Impaired Emotional Responses in a Pilocarpine-induced Post-status Epilepticus Rat Model.
Shishmanova-Doseva M; Tchekalarova J; Nenchovska Z; Ivanova N; Georgieva K; Peychev L
Folia Med (Plovdiv); 2020 Dec; 62(4):723-729. PubMed ID: 33415916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
